DHL expands medical and pharmaceutical logistics capacity in Germany

Leipzig is the second Forwarding facility to be expanded


Post a Press Release


Browse Top 1000 Lists


DHL Global Forwarding has expanded its Life Sciences & Healthcare (LSH) facility in Leipzig, Germany, by approximately 2,500 m2. The centre is very close to Leipzig Airport and houses state-of-the-art equipment for storing and handling temperature-controlled pharmaceutical and medical products, such as vaccinations.

After Frankfurt am Main, Leipzig is the second DHL Global Forwarding facility to be expanded in terms of capacity and equipment. DHL has successfully achieved IATA CEIV Pharma recertification for its GxP (good practice) facilities in Frankfurt am Main, Hamburg and Leipzig, making the Company ideally prepared in Germany to meet the logistical requirements related to importing and exporting Covid-19 vaccinations.

The previous transshipment and warehouse space of approximately 2,200 m2 in Leipzig was more than doubled when the expansion was completed in the last quarter of 2020. The second warehouse covers more than 2,500 m2 and is divided into two temperature zones. In the larger zone comprising approximately 1,700 m2, the temperature can be regulated between 15 and 25C.

The smaller zone of around 850 m2 can be cooled down to 2-8C. This allows pharmaceutical products to be stored at an appropriately cool temperature, to ensure their integrity. Dry ice handling for passively cooled transport containers and handling of actively cooled transport containers are also part of the standard repertoire. The immediate proximity to Leipzig Airport ensures fast import and export times. Of course, the facility also operates under the highest safety and security standards, with systems in place to immediately report temperature deviations and fire risks, as well as break-ins.


More from: | Category: Logistics Company News